No todo es Zika: Toxoplasmosis congénita, ¿aún prevalente en Colombia?
Revista Peruana de Medicina Experimental y Salud Pública, June 2017
Jorge L. Alvarado-Socarras, Keyla Meneses-Silvera, Andrea Carolina Zarate-Vergara, Carlos Guerrero-Gomez, Alfonso J. Rodriguez-Morales
Congenital toxoplasmosis continues to be a public health threat. Even existing guidelines, publicly known, its implementation and lack of appropriate interpretation of serological tests in pregnancy is often observed. This leds to failure in opportunities for positive and known interventions to decrease the fetal risk due to Toxoplasma gondii infection. We reported herein a case series, with variable neurological and systemic compromise (respiratory distress, hepatosplenomegaly, enterocolitis, brain calcifications, thrombocytopenia, ascites, shock), even fatal, calling for awareness about the fact that despite the Zika epidemics in 2015-2016 in Brazil, Colombia and other countries, precisely toxoplasmosis, is a differential diagnosis still prevalent in these territories, that can leds to severe consequences, with neurological disability and risk of ocular damage, even lately. Additionally, with varieties of T. gondii with more aggressive patterns in Latin America, which make worse those cases, including also a higher risk of death.
|Members of the public||1||50%|
|Readers by professional status||Count||As %|
|Student > Bachelor||10||21%|
|Student > Doctoral Student||6||13%|
|Student > Master||5||10%|
|Student > Ph. D. Student||5||10%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||11||23%|
|Agricultural and Biological Sciences||5||10%|
|Pharmacology, Toxicology and Pharmaceutical Science||3||6%|
|Nursing and Health Professions||2||4%|